Rating Change
Citizens analysts reiterated a Market Outperform rating on Exelixis, Inc. (NASDAQ:EXEL) on June 24, 2026.
reiterateNASDAQ:EXEL
Citizens Reiterates Market Outperform Rating on Exelixis, Inc. (EXEL)
Rating Change Citizens analysts reiterated a Market Outperform rating on Exelixis, Inc. (NASDAQ:EXEL) on June 24, 2026. Market Context Exelixis, Inc.
Market Context
Exelixis, Inc. operates in the Healthcare sector. The stock currently trades at $52.87 with a market capitalization of $11.1B. The stock has gained 21.9% over the past 52 weeks.
Analyst coverage from Citizens provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Exelixis, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Exelixis, Inc.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 24, 2026 | Citizens | Market Outperform | N/A |
| May 07, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 06, 2026 | Stifel | Hold | N/A |
| May 06, 2026 | Morgan Stanley | Equal-Weight | N/A |
| May 06, 2026 | TD Cowen | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View EXEL Stock Page
Frequently Asked Questions
What does a Market Outperform rating mean for EXEL?
A Market Outperform rating from Citizens reflects the analyst's outlook on Exelixis, Inc. (NASDAQ:EXEL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the EXEL forecast page.